Man-in-the-plant : FDA's failure to regulate deceptive drug labeling : report together with separate views /

FDA-approved bargain drugs : generic products must meet high standards.
Published: (2003)

Review Panel on New Drug Regulation : final report.
Published: (1977)

FDA drug bulletin.
Published: (1971)

Antibiotics : FDA needs to do more to ensure that drug labels contain up-to-date information : report to congressional committees.
Published: (2012)

Las drogas baratas aprobadas por la FDA : los productos genéricos deben satisfacer altos niveles.
Published: (2004)

Prescription drugs : FDA's oversight of the promotion of drugs for off-label uses : report to the Ranking Member, Committee on Finance, U.S. Senate.
Published: (2008)

Off-label drug use and FDA review of supplemental drug applications : hearing before the Subcommittee on Human Resources and Intergovernmental Relations of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, second session, September 12, 1996.
Published: (1997)

Off-label drug use and FDA review of supplemental drug applications : hearing before the Subcommittee on Human Resources and Intergovernmental Relations of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, second session, September 12, 1996.
Published: (1998)

El proceso del desarrollo de las drogas y la FDA : cómo la agencia asegura que las drogas sean seguras y efectivas.
Published: (2002)

Standardizing medication labels : confusing patients less : workshop summary /
Published: (2008)

Guidance for industry : implementation of Section 126 of the Food and Drug Administration Modernization Act of 1997, elimination of certain labeling requirements.
Published: (1998)

Food Labeling : FDA Needs To Better Leverage Resources, Improve Oversight, and Effectively Use Available Data To Help Consumers Select Healthy Foods.
Published: (2008)

FDA regulatory affairs : a guide for prescription drugs, medical devices, and biologics /
Published: (2004)

Drugs@FDA.

Forbidden cures. /
by: Fredman, Steven
Published: (1976)

Prescription Drugs : FDA Guidance and Regulations Related to Data on Elderly Persons in Clinical Drug Trials.
Published: (2007)

Food labeling : FDA needs to reassess its approach to protecting consumers from false or misleading claims : report to congressional committees.
Published: (2011)

Guidance for industry : providing regulatory submissions in electronic format, drug establishment registration and drug listing.
Published: (2008)

Drug shortages : FDA's ability to respond should be strengthened : report to congressional requesters.
Published: (2011)

FDA's Faulty Safeguards Against Corruption : Concerns over Debarment Use and Authority.
Published: (2008)

Drug regulation reform--oversight : hearing before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-sixth Congress, second session ...
Published: (1980)

Drug safety : better data management and more inspections are needed to strengthen FDA's foreign drug inspection program : report to congressional requesters.
Published: (2008)

Drug labeling in developing countries.
Published: (1993)

DailyMed.
Published: (2005)

FDA's drug approval process : up to the challenge? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining Food and Drug Administration's (FDA) drug approval process, focusing on FDA's drug approval process after a sponsor demonstrates that their benefits outweigh their risks for a specific population and use, and that the drug meet [as printed] meets standards for safety and efficacy, March 1, 2005.
Published: (2005)

FDA's drug approval process : up to the challenge? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining Food and Drug Administration's (FDA) drug approval process, focusing on FDA's drug approval process after a sponsor demonstrates that their benefits outweigh their risks for a specific population and use, and that the drug meet [as printed] meets standards for safety and efficacy, March 1, 2005.
Published: (2005)

U.S. Food and Drug Administration announcement related to certain sleep disorder drugs.
Published: (2007)

Food labeling : FDA needs to better leverage resources, improve oversight, and effectively use available data to help consumers select healthy foods : report to the Chair, Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies, Committee on Appropriations, House of Representatives.
Published: (2008)

Food and Drug Administration : agency complied with statutory requirement to reexamine condom labels.
by: King, Kathleen
Published: (2008)

Examining Concerns Regarding FDA's Proposed Changes to Generic Drug Labeling.
Published: (2014)

FDA's generic drug enforcement and approval process : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, March 7 and June 5, 1991.
Published: (1992)

The Food and Drug Administration's process for approving new drugs : report /
Published: (1980)

Amending the Federal Food, Drug, and Cosmetic Act to require labeling containing information applicable to pediatric patients : report together with additional views (to accompany S. 2394).
Published: (2002)

Drug shortages : FDA's ability to respond should be strengthened : testimony before the Committee on Health, Education, Labor, and Pensions, U.S. Senate /
by: Crosse, Marcia
Published: (2011)

Decline in FDA Enforcement Efforts.
Published: (2005)

FDA's generic drug approval process : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, first session.
Published: (1989)